{"id":"https://openalex.org/W4310093293","doi":"https://doi.org/10.1182/blood-2022-169430","title":"Practice Gaps and Barriers in Optimal Care Among Healthcare Professionals Treating Patients with CLL and MCL with BTK Inhibitors: Results of a 2-Phase Qualitative/Quantitative Study","display_name":"Practice Gaps and Barriers in Optimal Care Among Healthcare Professionals Treating Patients with CLL and MCL with BTK Inhibitors: Results of a 2-Phase Qualitative/Quantitative Study","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310093293","doi":"https://doi.org/10.1182/blood-2022-169430"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-169430","doi":"https://doi.org/10.1182/blood-2022-169430","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-169430","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025056133","display_name":"Ryan P. Topping","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan P. Topping","raw_affiliation_strings":["1Clinical Care Options, LLC, Reston, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Clinical Care Options, LLC, Reston, VA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alexandra Howson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandra Howson","raw_affiliation_strings":["2Thistle Editorial, LLC, Snoqualmie, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Thistle Editorial, LLC, Snoqualmie, WA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089950983","display_name":"Timothy A. Quill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy A. Quill","raw_affiliation_strings":["1Clinical Care Options, LLC, Reston, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Clinical Care Options, LLC, Reston, VA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082892912","display_name":"Christopher R. Flowers","orcid":"https://orcid.org/0000-0002-9524-3990","observed_orcids":["https://orcid.org/0000-0002-9524-3990"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher R. Flowers","raw_affiliation_strings":["3Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013007045","display_name":"Jeff Porter Sharman","orcid":"https://orcid.org/0000-0001-5611-6115","observed_orcids":["https://orcid.org/0000-0001-5611-6115"]},"institutions":[{"id":"https://openalex.org/I4210148213","display_name":"Willamette Valley Cancer Institute and Research Center","ror":"https://ror.org/05jr8e497","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210148213"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff P. Sharman","raw_affiliation_strings":["4Willamette Valley Cancer Institute and US Oncology Research, Eugene, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Willamette Valley Cancer Institute and US Oncology Research, Eugene, OR","institution_ids":["https://openalex.org/I4210148213"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.21066925,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"13090","last_page":"13091"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11744","display_name":"Health Sciences Research and Education","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12664","display_name":"Clinical practice guidelines implementation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.9330000281333923},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":1.0},{"id":"https://openalex.org/keywords/practice-gaps","display_name":"practice gaps","score":0.7680000066757202},{"id":"https://openalex.org/keywords/health-professionals-knowledge","display_name":"health professionals' knowledge","score":0.6729999780654907},{"id":"https://openalex.org/keywords/treatment-decision-making","display_name":"treatment decision-making","score":0.6079999804496765},{"id":"https://openalex.org/keywords/btk-inhibitor-resistance","display_name":"BTK inhibitor resistance","score":0.597000002861023},{"id":"https://openalex.org/keywords/relapsed-refractory-disease","display_name":"relapsed/refractory disease","score":0.7540000081062317},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.5460000038146973},{"id":"https://openalex.org/keywords/clinical-trial-referral","display_name":"clinical trial referral","score":0.5659999847412109},{"id":"https://openalex.org/keywords/evidence-based-education","display_name":"evidence-based education","score":0.5139999985694885},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.6600000262260437},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.7373755574226379},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.6409374475479126},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5571896433830261},{"id":"https://openalex.org/C3019806175","wikidata":"https://www.wikidata.org/wiki/Q11974939","display_name":"Health professionals","level":3,"score":0.5012722015380859},{"id":"https://openalex.org/C190248442","wikidata":"https://www.wikidata.org/wiki/Q839486","display_name":"Qualitative research","level":2,"score":0.5006999969482422},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4699331223964691},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3450757563114166},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.33344554901123047},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33143770694732666},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3292333483695984},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.32043910026550293},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2576441168785095},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.12454015016555786},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.10567927360534668},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.09601014852523804},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-169430","doi":"https://doi.org/10.1182/blood-2022-169430","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-169430","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Peace, justice, and strong institutions","score":0.5299999713897705,"id":"https://metadata.un.org/sdg/16"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389219879","https://openalex.org/W4405048117","https://openalex.org/W4405042597","https://openalex.org/W4405053198","https://openalex.org/W2523247821","https://openalex.org/W4385655405","https://openalex.org/W2980626933","https://openalex.org/W2949933568","https://openalex.org/W2971404913","https://openalex.org/W2951409648"],"abstract_inverted_index":{"Background:":[0],"Multiple":[1],"BTK":[2,423],"inhibitors":[3],"(BTKis)":[4],"are":[5],"approved":[6,287,437],"for":[7,109,155,237,277,317,350,465],"treating":[8],"patients":[9,58,122,239,351,409,466,504],"with":[10,20,59,63,123,198,240,320,329,352,357,369,380,385,410,444,467,472,489],"chronic":[11],"lymphocytic":[12],"leukemia":[13],"(CLL)":[14],"and":[15,43,61,95,105,111,152,157,162,182,206,210,234,263,274,279,290,295,322,326,399,412,459,469,482,508,537,549],"mantle":[16],"cell":[17],"lymphoma":[18],"(MCL),":[19],"further":[21],"approvals":[22],"expected":[23],"in":[24,34,51,98,150,192,208,224,230,271,344,375,408,461,480],"the":[25,29,52,64,68,128,193,261,272,393,419,445,475,530,552,557],"near":[26],"future,":[27],"increasing":[28],"clinical":[30,148,297,494,506,516,533],"complexity":[31],"of":[32,54,66,70,107,132,170,174,179,248,258,282,284,292,302,339,372,387,396,421,429,449,451,477,487,512,523,532,551,554,556],"decision-making":[33],"patient":[35,212,319],"care.":[36,213],"This":[37],"study":[38,101,172,525],"sought":[39],"to":[40,56,116,189,286,309,347,418,474,498,501,528],"quantify":[41],"knowledge":[42,104,291,376,460],"practice":[44,225,251,517,559],"gaps":[45,252],"among":[46],"oncology":[47],"healthcare":[48],"professionals":[49],"(HCPs)":[50],"use":[53,106,476],"BTKis":[55,108,492],"treat":[57],"CLL":[60,110,124,156,209,241,278,321,354,411,468],"MCL,":[62,280,356,470],"goal":[65],"informing":[67],"design":[69,531],"evidence-based":[71],"education":[72],"interventions":[73],"aimed":[74],"at":[75],"addressing":[76],"these":[77,266,513],"gaps.":[78,560],"Methods:":[79],"From":[80],"November":[81],"2021":[82],"-":[83],"January":[84],"2022,":[85],"488":[86],"eligible":[87,503],"HCPs":[88,341,366,456],"(including":[89],"physicians,":[90,220],"physician":[91],"assistants,":[92],"nurse":[93],"practitioners,":[94],"pharmacists)":[96],"participated":[97],"a":[99,139,231,318,332,336,362,422,435],"2-phase":[100],"focused":[102],"on":[103,144,415,505],"MCL.":[112,126,158],"Participants":[113],"were":[114,160,196,219,253,307,367,377,441],"required":[115],"be":[117,544],"active":[118],"practitioners":[119],"who":[120],"treated":[121],"and/or":[125,242],"In":[127,426],"exploratory":[129],"qualitative":[130,262],"phase":[131,169],"this":[133,171,397,452,524],"study,":[134],"30":[135],"US":[136],"participants":[137],"completed":[138],"45-minute":[140],"telephone":[141],"interview":[142],"focusing":[143],"factors":[145],"that":[146,403],"influence":[147],"reasoning":[149],"selecting":[151],"providing":[153],"treatment":[154,204],"Interviews":[159],"transcribed,":[161],"thematic":[163],"analysis":[164,257],"was":[165],"performed.":[166],"The":[167],"quantitative":[168,194,264],"consisted":[173],"an":[175],"online":[176,388],"survey":[177,195,389],"composed":[178],"multiple-choice":[180],"questions":[181],"semantic":[183],"differential":[184],"rating":[185],"scales.":[186],"Respondents'":[187],"answers":[188,200],"each":[190,555],"question":[191],"compared":[197],"optimal":[199,268,358,463],"as":[201,361,518],"identified":[202,254,360,558],"by":[203],"guidelines":[205],"specialists":[207],"MCL":[211,243],"Results:":[214],"Of":[215],"responding":[216,304],"HCPs,":[217,305],"59%":[218],"64%":[221],"had":[222],"been":[223],">10":[226],"years,":[227],"73%":[228,235],"practiced":[229],"nonacademic":[232],"setting,":[233],"cared":[236],"\u226410":[238],"per":[244],"week.":[245],"A":[246,485],"group":[247],"7":[249],"core":[250],"through":[255],"combined":[256],"data":[259],"from":[260],"surveys;":[265],"included":[267],"therapy":[269,313,348],"selection":[270,349],"first-":[273,481],"later-line":[275,483],"settings":[276],"awareness":[281],"mechanisms":[283,371],"resistance":[285],"BTKi":[288,370],"therapy,":[289],"investigational":[293],"therapies":[294],"appropriate":[296],"trial":[298],"referral.":[299],"For":[300],"example,":[301],"270":[303],"47%":[306],"unable":[308],"select":[310],"preferred":[311],"first-line":[312],"(per":[314],"expert":[315],"recommendations)":[316],"high":[323],"tumor":[324],"burden":[325],"renal":[327],"insufficiency,":[328],"9%":[330],"recommending":[331,434],"chemoimmunotherapy":[333],"regimen.":[334],"Likewise,":[335],"significant":[337],"percentage":[338],"surveyed":[340],"lacked":[342],"confidence":[343,458],"their":[345],"approach":[346],"relapsed/refractory":[353],"or":[355,447],"sequencing":[359],"primary":[363],"concern.":[364],"Many":[365,455],"unfamiliar":[368],"action.":[373],"Gaps":[374],"particularly":[378,471],"evident":[379],"novel":[381,491],"BTKis,":[382,478],"including":[383,546],"pirtobrutinib,":[384],"46%":[386],"respondents":[390,430],"uncertain":[391],"about":[392],"noncovalent":[394],"mechanism":[395,448],"agent":[398,438],"only":[400],"33%":[401],"aware":[402],"pirtobrutinib":[404],"has":[405],"shown":[406],"activity":[407],"disease":[413],"progression":[414],"ibrutinib":[416],"due":[417],"appearance":[420],"C481":[424],"mutation.":[425],"total,":[427],"60%":[428],"would":[431],"not":[432,442],"consider":[433],"newly":[436],"if":[439],"they":[440],"familiar":[443],"class":[446],"action":[450],"agent.":[453],"Conclusions:":[454],"lack":[457,486],"applying":[462],"care":[464],"regard":[473],"both":[479],"therapy.":[484],"familiarity":[488],"promising":[490],"under":[493],"investigation":[495,550],"may":[496],"lead":[497],"missed":[499],"opportunities":[500],"enroll":[502],"trials":[507],"potentially":[509],"delay":[510],"integration":[511],"agents":[514],"into":[515],"new":[519],"indications":[520],"emerge.":[521],"Results":[522],"provide":[526],"evidence":[527],"support":[529],"tools,":[534],"educational":[535],"programs,":[536],"performance":[538],"improvement":[539],"interventions.":[540],"Detailed":[541],"findings":[542],"will":[543],"presented,":[545],"group-specific":[547],"analyses":[548],"causalities":[553]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2022-11-30T00:00:00"}